- 2-3 weeks for results
- No recovery needed
- 67%
China versus the U.S.
- China clinical rate
- $800 – $2,500
- $1,650
- United States
- $3,000 – $7,000
- $5,000
- You save
- ~67%
- $3,350 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Comprehensive genomic profiling of tumor tissue to identify actionable mutations and guide precision oncology treatment selection. China's molecular diagnostics labs offer extensive cancer gene panels covering 300-600+ genes with TMB and MSI analysis. Essential for identifying targeted therapy options, immunotherapy eligibility, and clinical trial matching.
Step by step.
Specimen Preparation
Tumor tissue biopsy or archived specimen retrieval, pathology confirmation of adequate tumor content.
Genomic Sequencing
Next-generation sequencing of comprehensive cancer gene panel with tumor mutational burden and microsatellite instability analysis.
Bioinformatics Analysis
Variant calling, annotation against cancer databases, actionability assessment, and drug sensitivity prediction.
Clinical Interpretation
Molecular tumor board review, treatment recommendations report, clinical trial matching, and oncologist consultation.
- Comprehensive 300-600+ gene panel at fraction of US cost
- Identification of targeted therapy and immunotherapy options
- Tumor mutational burden and MSI status for immunotherapy eligibility
- Access to China's clinical trial network for matched therapies
- Not all identified mutations have approved targeted therapies
- Tumor heterogeneity may not be captured by single biopsy
- Insufficient tumor tissue may require repeat biopsy
- Genomic profiling cannot predict treatment response with certainty
Ask the AI for hospitals that handle cancer genomic profiling.
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.